Global Tasigna Market, By Type (50mg, 200mg, Others), Application (Chronic Myeloid Leukemia (CML), Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), Demographic (Adults, Pediatric), Side Effects (Headache, Nausea, Vomiting, Constipation, Cough, Diarrhea, Rash, Night Sweats, Muscle Pain, Tiredness, Temporary Hair Loss, Sore Throat, Runny or Stuffy Nose, Sneezing, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Tasigna Market
Tasigna market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 7.0% in the above mentioned forecast period.
Tasigna is defined as a prescription medicine which used to treat a type of blood cancer called chronic myeloid leukemia. This medication belong the class of drugs known as antineoplastic, tyrosine kinase inhibitor. Nilotinib is the generic name of this cancer medication. Side effects of this drug are headache, nausea, vomiting, constipation, cough, diarrhea, rash, night sweats, muscle pain, tiredness, temporary hair loss, sore throat, runny or stuffy nose, speech problems, sneezing and breathing difficulty.
The rise in the prevalence of blood cancer and growing healthcare expenditure are the major factors influencing the market growth rate. Furthermore, growing demand for novel therapies and treatment, advancement of medical technology, growing government funding are the factors that will expand the tasigna market. Also, changing lifestyle and increase in the disposable income are the drivers that will cushion the market growth rate.
Rise in the research and development activities and ongoing clinical trials will provide beneficial opportunities for the tasigna market in the forecast period of 2021-2028.
However, high cost of treatment and side effects associated with the medication are the factors that will hinder the market growth. Strict government regulations and less awareness will further challenge the tasigna market in the forecast period mentioned above.
This tasigna market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tasigna market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Tasigna Market Scope and Market Size
The tasigna market is segmented on the basis of type, application, dosage, route of administration, demographic, side effects, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the tasigna market is segmented into 50mg, 200mg and others.
- On the basis of application, the tasigna market is segmented into chronic myeloid leukemia (CML) and others.
- On the basis of dosage, the tasigna market is segmented into tablet, injection and others.
- On the basis of route of administration, the tasigna market is segmented into oral, intravenous and others.
- On the basis of demographic, the tasigna market is segmented into adults and pediatric.
- On the basis of side effects, the tasigna market is segmented into headache, nausea, vomiting, constipation, cough, diarrhea, rash, night sweats, muscle pain, tiredness, temporary hair loss, sore throat, runny or stuffy nose, sneezing and others.
- On the basis of end-users, the tasigna market is segmented into clinic, hospital and others.
The tasigna market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Tasigna Market Country Level Analysis
Tasigna market is analyzed and market size information is provided by the country, type, application, dosage, route of administration, demographic, side effects, end-users and distribution channel as referenced above.
The countries covered in the tasigna market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the tasigna market due to the presence of major key players, growing investment for R&D activities, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Tasigna market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Tasigna Market Share Analysis
Tasigna market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global tasigna market research.
The major players covered in the tasigna market report are Novartis AG, Merck Sharp & Dohme Corp., AstraZeneca, Harbin Pharmaceutical Group, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-